Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shinich, Hori"'
Autor:
Kohei Morita, Toshihiro Tanaka, Chiho Obayashi, Shinich Hori, Tetsuya Masada, Kimihiko Kichikawa, Masaaki Kaneko, Takeshi Sato, Shota Tatsumoto, Nagaaki Marugami, Ai Kijima, Yasushi Fukuoka, Hideyuki Nishiofuku
Publikováno v:
CardioVascular and Interventional Radiology. 41:1412-1418
To analyze size changes of superabsorbent polymer (SAP) microspheres with the reduced expansion technique, and to evaluate pharmacological advantages of transarterial chemoembolization using cisplatin-loaded SAP microspheres with the reduced expansio
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 43(12)
Melanoma is a potentially aggressive disease, and patients with metastatic melanoma have a poor prognosis, with a median survival of only 6-9 months. There is no effective standard treatment for liver metastasis of malignant melanoma. Primary ovarian
Publikováno v:
CardioVascular and Interventional Radiology. 34:557-565
To evaluate the safety, clinical outcomes, and hepatic artery damage after transcatheter arterial chemoembolization (TACE) with epirubicin-loaded superabsorbent polymer microspheres (ELM-TACE) in patients with hepatocellular carcinoma (HCC) in a sing
Publikováno v:
VLSI-DAT
To realize extremely high data rate of 50M-1Gbps in the 4G era, innovative circuit technologies for wider bandwidth and higher spectrum efficiency are required. In addition, some technical problems arise from increasing network density. For these tec
Autor:
Akihiko Seki, Shinich Hori
Publikováno v:
Cardiovascular and interventional radiology. 35(3)
There is no consensus on switching anticancer agents loaded onto drug carriers in transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). This study aimed to evaluate the safety and clinical outcomes of TACE with cisplatin
Autor:
Akihiko Seki, Shinich Hori
Publikováno v:
International journal of clinical oncology. 16(5)
This is the first case report describing transcatheter arterial chemoembolization (TACE) with docetaxel-loaded microspheres which was successful in controlling liver metastases. We report on a 50-year-old woman with unresectable liver metastases from